Innovator Ibd 50 Etf Performance

FFTY Etf  USD 39.00  0.01  0.03%   
The etf retains a Market Volatility (i.e., Beta) of 1.46, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Innovator IBD will likely underperform.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Innovator IBD 50 has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Innovator IBD is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
1
Will Innovator IBD 50 ETF stock justify high valuation - July 2025 Drop Watch Daily Market Momentum Tracking - newser.com
11/06/2025
2
Is Innovator IBD 50 ETF stock a buy on weakness - Weekly Trend Report Smart Money Movement Alerts - newser.com
11/13/2025
3
Eldorado Gold And Other Gold Stocks Enter IBD Watchlists - Investors Business Daily
11/18/2025
4
How Innovator IBD 50 ETF stock moves on employment data - Earnings Risk Report Real-Time Volume Spike Alerts - Newser
12/04/2025
5
Technical Reactions to FFTY Trends in Macro Strategies - Stock Traders Daily
01/22/2026

Innovator IBD Relative Risk vs. Return Landscape

If you would invest  3,982  in Innovator IBD 50 on October 28, 2025 and sell it today you would lose (156.00) from holding Innovator IBD 50 or give up 3.92% of portfolio value over 90 days. Innovator IBD 50 is currently does not generate positive expected returns and assumes 2.1128% risk (volatility on return distribution) over the 90 days horizon. In different words, 18% of etfs are less volatile than Innovator, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Innovator IBD is expected to under-perform the market. In addition to that, the company is 2.87 times more volatile than its market benchmark. It trades about -0.02 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of volatility.
Below is the normalized historical share price chart for Innovator IBD 50 extending back to April 09, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Innovator IBD stands at 39.00, as last reported on the 26th of January, with the highest price reaching 38.99 and the lowest price hitting 37.77 during the day.
3 y Volatility
23.98
200 Day MA
33.8455
1 y Volatility
23.71
50 Day MA
35.6006
Inception Date
2015-04-08
 
Yuan Drop
 
Covid
 
Interest Hikes

Innovator IBD Target Price Odds to finish over Current Price

The tendency of Innovator Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 39.00 90 days 39.00 
about 7.66
Based on a normal probability distribution, the odds of Innovator IBD to move above the current price in 90 days from now is about 7.66 (This Innovator IBD 50 probability density function shows the probability of Innovator Etf to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the etf has the beta coefficient of 1.46 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Innovator IBD will likely underperform. Additionally Innovator IBD 50 has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Innovator IBD Price Density   
       Price  

Predictive Modules for Innovator IBD

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Innovator IBD 50. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Innovator IBD's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
36.1638.2740.38
Details
Intrinsic
Valuation
LowRealHigh
35.6837.7939.90
Details
Naive
Forecast
LowNextHigh
36.8538.9641.07
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
34.3036.4938.68
Details

Innovator IBD Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Innovator IBD is not an exception. The market had few large corrections towards the Innovator IBD's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Innovator IBD 50, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Innovator IBD within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.12
β
Beta against Dow Jones1.46
σ
Overall volatility
2.03
Ir
Information ratio -0.04

Innovator IBD Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Innovator IBD for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Innovator IBD 50 can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Innovator IBD 50 generated a negative expected return over the last 90 days
Latest headline from news.google.com: Technical Reactions to FFTY Trends in Macro Strategies - Stock Traders Daily
The fund created five year return of -2.0%
Innovator IBD 50 retains 99.92% of its assets under management (AUM) in equities

Innovator IBD Fundamentals Growth

Innovator Etf prices reflect investors' perceptions of the future prospects and financial health of Innovator IBD, and Innovator IBD fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Innovator Etf performance.

About Innovator IBD Performance

Evaluating Innovator IBD's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Innovator IBD has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Innovator IBD has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
The fund will normally invest at least 80 percent of its net assets in securities that comprise the index. Innovator Ibd is traded on NYSEARCA Exchange in the United States.
Innovator IBD 50 generated a negative expected return over the last 90 days
Latest headline from news.google.com: Technical Reactions to FFTY Trends in Macro Strategies - Stock Traders Daily
The fund created five year return of -2.0%
Innovator IBD 50 retains 99.92% of its assets under management (AUM) in equities
When determining whether Innovator IBD 50 offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innovator IBD's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innovator Ibd 50 Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Innovator Ibd 50 Etf:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Innovator IBD 50. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
The market value of Innovator IBD 50 is measured differently than its book value, which is the value of Innovator that is recorded on the company's balance sheet. Investors also form their own opinion of Innovator IBD's value that differs from its market value or its book value, called intrinsic value, which is Innovator IBD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovator IBD's market value can be influenced by many factors that don't directly affect Innovator IBD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovator IBD's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innovator IBD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovator IBD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.